The overexpression of 14‐3‐3ζ and Hsp27 promotes non–small cell lung cancer progression

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|120|5|652-663

ISSN： 0008-543x

Source： CANCER, Vol.120, Iss.5, 2014-03, pp. : 652-663

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

14-3-3ζ Overexpression and abnormal β-catenin expression are associated with poor differentiation and progression in stage I non-small cell lung cancer

By Zang Dongyu   Li Xiaoming   Zhang Lin  

Clinical and Experimental Medicine, Vol. 10, Iss. 4, 2010-12 ,pp. : 221-228

Springer Publishing Company

Access to resources Recommend Favorite

Docetaxel in non-small cell lung cancer

By Souquet Pierre-Jean   Geriniere Laurence  

Therapy, Vol. 3, Iss. 5, 2006-09 ,pp. : 579-590

Future Medicine

Access to resources Recommend Favorite

Ifosfamide in Non-Small Cell Lung Cancer

By  

Oncology, Vol. 65, Iss. 2, 2003-11 ,pp. : 50-54

Karger

Access to resources Recommend Favorite

The Influence of Sex in Non-Small Cell Lung Cancer

By  

Oncology Research and Treatment, Vol. 32, Iss. 10, 2009-09 ,pp. : 547-548

Karger

Access to resources Recommend Favorite

Gallbladder Metastasis of Non-Small Cell Lung Cancer

By  

Oncology Research and Treatment, Vol. 27, Iss. 4, 2004-09 ,pp. : 398-400

Karger

Access to resources Recommend Favorite